Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Operating activities:
Net income (loss)	$ (20,506)	$ (286)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	331	379
Amortization of right-of-use assets	349	347
Stock-based compensation	1,023	1,546
Issuance of common stock to underwriter		667
Change in provision for credit losses	1,366	(547)
Change in fair value of warrant liabilities	(639)	(2,002)
Change in fair value of convertible promissory notes	176	1,189
Change in fair value of common stock forward liability	(295)	586
Gain on extinguishment of liability	0	(14,636)
Changes in operating assets and liabilities:
Accounts receivable	548	253
Inventory	(18)	(511)
Contract assets	(855)	(1,176)
Prepaid expenses and other current assets	1,346	(1,702)
Other assets	79	44
Accounts payable	(483)	(3,356)
Contract liabilities	(24)	(25)
Accrued and other current liabilities	1,188	(4,407)
Net defined benefit liabilities	1,132	351
Income tax payable	(324)	(29)
Lease liabilities	(794)	(341)
Other liabilities	(189)	(406)
Net cash used in operating activities	(16,589)	(24,062)
Investing activities:
Purchases of property and equipment	(209)	(131)
Net cash used in investing activities	(209)	(131)
Financing activities:
Proceeds from reverse recapitalization and PIPE Financing, net of transaction costs		17,238
Proceeds from issuance of convertible promissory notes		16,290
Proceeds from borrowings	7,500
Proceeds from issuance of common stock under at-market agreement	487
Proceeds from issuance of common stock under common stock purchase agreement	190	2,815
Proceeds from exercise of stock options	21
Proceeds from issuance of common stock and common stock warrants in a registered direct offering	11,000
Payment of common stock issuance costs	(847)
Tax withholding on restricted stock units	(11)
Repayments of borrowings	(2,212)	(7,853)
Repayments of convertible promissory notes		(630)
Net cash provided by financing activities	16,128	27,860
Effect of exchange rate changes on cash and cash equivalents	501	110
Net increase (decrease) in cash and cash equivalents	(169)	3,777
Cash and cash equivalents at beginning of period	1,435	258
Cash and cash equivalents at end of period	1,266	4,035
Supplemental disclosure of cash flow information:
Cash paid for interest	2,711	2,144
Cash paid for income taxes	65	47
Cash paid for operating leases	361	377
Non-cash financing activities:
Unpaid common stock issuance costs included in accounts payable	275
Issuance of common stock from conversion of convertible promissory notes		41,209
Settlement of common stock forward liability in equity		51
Proceeds from issuance of common stock withheld for outstanding payables		$ 488
Operating lease right-of-use assets obtained in exchange for operating lease liabilities	$ 61